90 related articles for article (PubMed ID: 11764659)
1. Functional evaluation of the human pancreas before and in the early period after hyperfractionated accelerated radiochemotherapy.
Horst E; Seidel M; Micke O; Rübe C; Schäfer U; Willich N
Front Radiat Ther Oncol; 2002; 37():17-25. PubMed ID: 11764659
[No Abstract] [Full Text] [Related]
2. Unresolved issues in the management of locally advanced non-metastatic pancreas cancer.
Khoo VS; Price P
Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):303-7. PubMed ID: 12206643
[No Abstract] [Full Text] [Related]
3. Accelerated radiochemotherapy in pancreatic cancer is not necessarily related to a pathologic pancreatic function decline in the early period.
Horst E; Seidel M; Micke O; Rübe C; Glashörster M; Schäfer U; Willich NA
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):304-9. PubMed ID: 11872274
[TBL] [Abstract][Full Text] [Related]
4. Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy.
Micke O; Hesselmann S; Bruns F; Horst E; Devries A; Schüller P; Willich N; Schäfer U
Anticancer Res; 2005; 25(3A):1523-30. PubMed ID: 16033054
[TBL] [Abstract][Full Text] [Related]
5. Pilot study in locally advanced unresectable pancreas carcinoma using a combination of accelerated radiotherapy and continuous infusion of 5-fluorouracil.
Luderhoff EC; González González D; Bakker P
Radiother Oncol; 1996 Sep; 40(3):241-3. PubMed ID: 8940751
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer.
Ueno H; Okusaka T; Ikeda M; Tokuuye K
Oncology; 2004; 67(3-4):215-21. PubMed ID: 15557781
[TBL] [Abstract][Full Text] [Related]
7. Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas.
Wong AA; Delclos ME; Wolff RA; Evans DB; Abbruzzese JL; Tamm EP; Xiong HQ; Ho L; Crane CH;
Am J Clin Oncol; 2005 Jun; 28(3):227-33. PubMed ID: 15923793
[TBL] [Abstract][Full Text] [Related]
8. Unresectable adenocarcinoma of the pancreas: patterns of failure and treatment results.
Paulino AC; Latona C
Cancer Invest; 2000; 18(4):309-13. PubMed ID: 10808366
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the pancreatic head area. Therapy: concomitant radiochemotherapy.
Cellini N; Valentini V; Trodella L; Balducci M; Morganti AG; Turriziani A
Rays; 1995; 20(3):350-9. PubMed ID: 8559976
[TBL] [Abstract][Full Text] [Related]
10. [Change of 5-fluorouracil penetration in blood-pancreatic barrier of rats after high-dose radiotherapy].
Kang W; Zhao Y; Tao W; Cai L; Zhu Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Oct; 22(5):457-9. PubMed ID: 12903428
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma.
Hsue V; Wong CS; Moore M; Erlichman C; Cummings BJ; MacLeod M
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):445-50. PubMed ID: 8567347
[TBL] [Abstract][Full Text] [Related]
12. Concomitant radiochemotherapy in unresectable carcinoma of the exocrine pancreas: cost-effectiveness analysis.
Cellini N; Costamagna G; Morganti AG; Valentini V; Macchia G; Mutignani M; Pandolfi M; Trodella L
Rays; 1999; 24(3):447-52. PubMed ID: 10605305
[TBL] [Abstract][Full Text] [Related]
13. Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study.
Prott FJ; Schönekaes K; Preusser P; Ostkamp K; Wagner W; Micke O; Pötter R; Sulkowski U; Rübe C; Berns T; Willich N
Br J Cancer; 1997; 75(4):597-601. PubMed ID: 9052417
[TBL] [Abstract][Full Text] [Related]
14. Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil.
Mawdsley S; Hall M; Glynne-Jones R
Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):308-12. PubMed ID: 12206644
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiation of unresectable pancreatic carcinoma: impact of pretreatment hemoglobin level on patterns of failure.
Morganti AG; Forni F; Macchia G; Valentini V; Smaniotto D; Trodella L; Balducci M; Cellini N
Strahlenther Onkol; 2003 Feb; 179(2):87-92. PubMed ID: 12590318
[TBL] [Abstract][Full Text] [Related]
16. [Pancreatic cancer. The relative importance of neoadjuvant therapy].
Beger HG; Poch B; Schwarz M; Gansauge F
Chirurg; 2003 Mar; 74(3):202-7. PubMed ID: 12647076
[TBL] [Abstract][Full Text] [Related]
17. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.
Pisters PW; Abbruzzese JL; Janjan NA; Cleary KR; Charnsangavej C; Goswitz MS; Rich TA; Raijman I; Wolff RA; Lenzi R; Lee JE; Evans DB
J Clin Oncol; 1998 Dec; 16(12):3843-50. PubMed ID: 9850029
[TBL] [Abstract][Full Text] [Related]
18. A challenge to the therapeutic nihilism of ESPAC-1.
Koshy MC; Landry JC; Cavanaugh SX; Fuller CD; Willett CG; Abrams RA; Hoffman JP; Thomas CR
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):965-6. PubMed ID: 15752874
[No Abstract] [Full Text] [Related]
19. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy.
Micke O; Bruns F; Kurowski R; Horst E; deVries AF; Hausler JW; Willich N; Schäfer U
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):90-7. PubMed ID: 12909220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
